STAT+: Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugs
Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.
health_news
Indian Pharma Market Kicks Off 2026 With 10% Growth in January: PharmaTrac
New Delhi: The Indian Pharmaceutical Market (IPM) started calendar year 2026 with a robust uptick, delivering 10.21% month-on-month value growth and 1.82% unit growth in January, data from PharmaTrac MAT…
USFDA Issues 9 Observations to Aurobindo’s Jedcherla Unit-VII After Inspection
New Delhi: Aurobindo Pharma Limited recently informed that the United States Food and Drug Administration (USFDA) has completed an inspection at its Unit-VII manufacturing facility located at Jedcherla in Telangana.…
GST Probe at Mankind Pharma’s BSV Unit in Mumbai
New Delhi: Mankind Pharma Limited has informed the stock exchanges that the Goods and Services Tax (GST) Department, Mumbai, carried out a search and inspection operation at Bharat Serums and…
OneSource Secures Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout
New Delhi: OneSource Specialty Pharma Limited has received regulatory approval in Saudi Arabia to commercialise a generic version of Ozempic (semaglutide), marking a significant milestone for the company's expansion in…
STAT+: FDA’s rejection of Moderna threatens to stifle broader vaccine industry
Experts say the FDA "moved the goalposts" on Moderna, creating "a destructive precedent that will undermine the future of vaccine development" in the U.S.
Lupin Gets 1 Observation for Tarapur Facility After USFDA cGMP Inspection
Mumbai: Pharma major Lupin has announced the completion of a cGMP inspection carried out by the United States Food and Drug Administration (USFDA) at its Tarapur facility. The inspection closed…
Falls Common Among Lupus Patients, Linked to Multiple Risk Factors: Study
Findings from the APPEAL study, published in ACR Open Rheumatology, reveal that falls are a frequent but underrecognized complication among individuals with systemic lupus erythematosus (SLE). Researchers analyzed data from…
STAT+: The messaging war over Medicaid cuts
This is the web edition of STAT's D.C. Diagnosis newsletter.
STAT+: NIH redefines ‘clinical trials,’ dividing researchers
In a long-debated move, the NIH will no longer characterize basic experimental studies involving humans as clinical trials.